Here, we examined the possible exacerbating cognitive and histopathological impact of TBI on AD in presymtomatic APP/PS-1 AD-transgenic mice and non-transgenic (NT) mice using the controlled cortical impact (CCI) model. This evidence concerns the gene APP and Alzheimer disease.